Month: December 2020

WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of 1.5 million shares of its common stock. In addition, Repligen Corporation expects to grant the underwriters a 30-day option to purchase up to an additional 225,000 shares of its common stock in connection with the proposed public offering. All shares of common stock will be offered by Repligen Corporation. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.Repligen Corporation intends to use the net proceeds from this offering for working capital and other general corporate purposes. Net proceeds from this offering may also be used to fund...

MISSISSAUGA, Ontario, Dec. 07, 2020 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces that Mr. Anthony J. Giovinazzo, an accomplished leader in the international life sciences industry, has joined its Board of Directors.Mr. Giovinazzo joined the Board of Directors effective today, and was also appointed as a member of the Audit Committee and the Human Resources, Compensation & Governance Committee.Mr. Giovinazzo has over 40 years of life sciences experience and is an internationally-recognized expert in life sciences intellectual property, drug development, and product commercialization. As CEO of Cynapsus Therapeutics Inc., he co-invented and led the development and commercialization of the now Health Canada and U.S. FDA approved Parkinson’s Disease...

Press ReleaseNokia and Vi CSR deploy SmartAgri solution to enhancefarming practices of 50,000 farmersVi CSR has deployed Nokia’s Worldwide IoT Network Grid (WING) solution to equip 50,000 farmers in India with precise and practical data to help them achieve better yieldsDeployment of the smart agriculture-as-a-service solution will include soil probes, weather stations, insect traps and crop cameras to help drive productivity of soy and cotton cropsVisit the Vi booth (Hall #3) at IMC 2020 from 8-10th December to know more about the program          07 December 2020Espoo, Finland – Nokia and Vodafone India Foundation, the CSR arm of Vi, have today announced that they have deployed a Smart Agriculture solution that aims to improve the productivity of farmers in India. The pilot project is being implemented in 100 locations in the states...

–Amended agreement encompasses enhanced manufacturing collaboration and regulatory support-Accelerates milestone payments to Nabriva, including fourth quarter 2020 payment of $1 millionDUBLIN, Ireland, Dec. 07, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced the restructuring of its license agreement with Sinovant Sciences for XENLETA™ (lefamulin) in the greater China region. The restructured agreement provides for additional manufacturing collaboration and regulatory support [to be provided to Sinovant by Nabriva] that is expected to help expedite the delivery of XENLETA to patients in greater China. The restructured agreement accelerates components of the...

THE WOODLANDS, Texas, Dec. 07, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the launch of a secondary website, LGIHomesActiveAdult.com. By endorsing communities that offer abundant amenities and promote an active lifestyle, this new site supports homebuyers on their journey to find the perfect home uniquely suited to their needs and desires.LGIHomesActiveAdult.com features a modern, simplistic design with beautiful photography and captivating copy that details the lifestyle that can be found at many LGI Homes communities. Additionally, LGIHomesActiveAdult.com showcases the company’s age-restricted active adult community as well as our Inspired Living communities. All the communities highlighted on this new site offer low-maintenance living and include amenities that support an active lifestyle.LGIHomesActiveAdult.com...

VANCOUVER, British Columbia, Dec. 07, 2020 (GLOBE NEWSWIRE) — FIRST MAJESTIC SILVER CORP. (AG: NYSE; FR: TSX) (the “Company” or “First Majestic”) is pleased to announce that the Company’s Board of Directors has adopted a dividend policy for the Company under which the Company intends to pay quarterly dividends of 1% of the Company’s net revenues commencing after the completion of the first quarter of 2021. In accordance with the rules of the Toronto Stock Exchange the Company will issue a press release at the time each quarterly dividend is declared.“The announcement of our inaugural dividend policy is a major milestone for the Company and validates the overall strength and sustainability of the business given our robust operations in Mexico,” stated Keith Neumeyer, President and CEO. “This new quarterly dividend also...

Preliminary data as of August 2020 from ongoing Phase 2a open label extension trial showed increases in HbF percentage and F-cells after approximately six months of treatmentCase reports showed additional improvements in clinical outcomes, hemoglobin and related biomarkers of hemolysisIMR-687 continued to be well tolerated as a monotherapy and in combination with hydroxyureaBOSTON, Dec. 07, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that it presented two case reports from the ongoing IMR-687 Phase 2a open label extension (OLE) clinical trial in adult patients with sickle cell disease (SCD) at the 62nd American Society of...

PRINCETON, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced the appointment of Marian Macsai, M.D., as Chief Medical Officer, and Eric Carlson, Ph.D., as Chief Scientific Officer, both of whom will join the executive leadership team, effective December 7, 2020.“I’m thrilled to welcome Drs. Macsai and Carlson to the executive leadership team at Oyster Point, as both will help expand and strengthen our organization during this time of unprecedented growth,” said Jeffrey Nau, Ph.D., MMS, president and chief executive officer at Oyster Point Pharma. “Based on their industry expertise and unique experience in...

MINNEAPOLIS, Dec. 07, 2020 (GLOBE NEWSWIRE) — OTCQB: (PETV) PetVivo Holdings, Inc. (www.petvivo.com) an emerging biomedical device company operating in the $19B veterinary market announced today it will be exhibiting at the American Association of Equine Practitioners (“AAEP”) Virtual Convention and Trade Show from December 5th to December 8th, 2020 that can be accessed online at https://convention.aaep.org/.PetVivo is excited to meet with many of the more than 1,000 participants to talk about and introduce its lead product, KUSH®, a medical device injection of sterilized, hydrogel microparticles that are wet, slippery and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis. AAEP is the largest veterinary equine conference in the United States and plays host to many of the top industry...

– PDUFA Goal Date Set for August 1, 2021– Potential to be the first acne treatment that contains a fixed-dose combination of benzoyl peroxide and tretinoinNESS ZIONA, Israel, Dec. 07, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that its New Drug Application (NDA) for Twyneo® (benzoyl peroxide and tretinoin), an investigational proprietary fixed-dose combination of 3% encapsulated benzoyl peroxide and 0.1% encapsulated tretinoin cream for the treatment of acne vulgaris, has been accepted for filing by the U.S. Food and Drug Administration (FDA). The Prescription Drug User Fee Act (PDUFA) goal date assigned by the...